Jazz Pharmaceuticals (JAZZ): Q2 EPS of $1.09 beats by $0.04. Revenue of $130M beats by $5M....

|About: Jazz Pharmaceuticals, Inc. (JAZZ)|By:, SA News Editor
Jazz Pharmaceuticals (JAZZ): Q2 EPS of $1.09 beats by $0.04. Revenue of $130M beats by $5M. Shares +2.4% AH.